← FDA Drug Approvals (Drugs@FDA)

AMBRISENTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2019-04-26

Drug application

FDA Application #

ANDA210715

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMBRISENTAN

Generic name

AMBRISENTAN

Active ingredients

AMBRISENTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2019-04-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown